Physician profile
Amit Misra
NPI 1750675807
$976.30
in general payments reported to CMS, 2019-2025
21 companies · $84.74 in 2025
The $84.74 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $221 · 2021: $78.45 · 2023: $92.82 · 2024: $500 · 2025: $84.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.31 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $227.79 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Philips North America LLC | $127.28 | 2024 | (Ak6) Vest Therapy, (5050) Extended Holter |
| Teva Pharmaceuticals USA, INC. | $74.78 | 2020-2021 | |
| Mylan Specialty L.P. | $64.04 | 2024 | Yupelri |
| Eisai INC. | $55.18 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $54.27 | 2023-2025 | Fasenra, Airsupra |
| Abbvie INC. | $35.37 | 2021 | |
| Radius Health, INC. | $34.98 | 2020 | |
| Genentech USA, INC. | $33.31 | 2020 | |
| Lilly USA, LLC | $32.38 | 2024 | Mounjaro |
| Pfizer INC. | $32.15 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $30.63 | 2024 | Dupixent |
| Itamar Medical INC | $29.14 | 2024 | Watchpatone |
| Janssen Pharmaceuticals, INC | $28.51 | 2020-2023 | Xarelto |
| Astellas Pharma US INC | $22.49 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.65 | 2024 | |
| United Therapeutics Corporation | $16.35 | 2023 | Tyvaso |
| Baxter Healthcare | $15.85 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Therapeuticsmd, INC. | $15.43 | 2020 | |
| Alkermes, INC. | $14.85 | 2025 | Vivitrol |
| Novo Nordisk INC | $13.87 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Misra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.